These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 4522738)

  • 1. The treatment of acute myeliod leukaemia.
    Friend JH; Giles C; Richardson SG
    J Clin Pathol; 1974 Jan; 27(1):53-4. PubMed ID: 4522738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute myeloid leukaemia according to the Hammersmith protocol: preliminary report.
    Paolino W; Resegotti L; Rossi M; Infelise V
    Br Med J; 1973 Sep; 3(5880):567-8. PubMed ID: 4516626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute granulocytic leukemia in elderly patients.
    Bloomfield CD; Theologides A
    JAMA; 1973 Dec; 226(10):1190-3. PubMed ID: 4518517
    [No Abstract]   [Full Text] [Related]  

  • 5. Preliminary results of a trial on acute myeloid leukemia comparing the effect of cytosine arabinoside, the combination of cytosine arabinoside and thioguanine and the combination of cytosine arabinoside and daunorubicine.
    Recent Results Cancer Res; 1973; 43():165-8. PubMed ID: 4531077
    [No Abstract]   [Full Text] [Related]  

  • 6. [Revaluation of the two step DCMP chemotherapy for acute leukemias (author's transl)].
    Nakaide Y; Tanaka M; Tanaka M; Fujiwara Y; Furukawa K; Hirota Y
    Rinsho Ketsueki; 1979 Oct; 20(10):1340-6. PubMed ID: 396387
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
    Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
    Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute myeloid leukaemia with cytosine arabinoside and daunomycin in combination.
    Brincker H
    Scand J Haematol; 1972; 9(6):657-64. PubMed ID: 4509284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
    Brincker H
    Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparative trial of remission induction (by cytosine arabinoside, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Biomedicine; 1973 May; 18(3):192-8. PubMed ID: 4517790
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of thioguanine on a combination of daunorubicine, cytarabine and prednisone in the treatment of acute leukaemia in adults. The Finnish Leukaemia Group.
    Scand J Haematol; 1979 Aug; 23(2):124-8. PubMed ID: 291122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin in the treatment of adult acute leukaemia.
    Burgess MA; Garson OM; de Gruchy GC
    Med J Aust; 1970 Mar; 1(13):629-35. PubMed ID: 5267172
    [No Abstract]   [Full Text] [Related]  

  • 14. A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia.
    Eur J Cancer (1965); 1974 Jul; 10(7):413-8. PubMed ID: 4532961
    [No Abstract]   [Full Text] [Related]  

  • 15. Prognosis of acute leukaemia in adults.
    Penington DG; Keating MJ
    Med J Aust; 1974 Jun; 1(26):1031-5. PubMed ID: 4527947
    [No Abstract]   [Full Text] [Related]  

  • 16. Daunorubicin-prednisone remission induction with hydroxyurea maintenance in acute non-lymphocytic leukemia.
    Bloomfield CD; Brunning RD; Theologides A; Kennedy BJ
    Cancer; 1973 Apr; 31(4):931-8. PubMed ID: 4513295
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of acute granulocytic leukemias.
    Bernard J; Weil M; Jacquillat C
    Annu Rev Med; 1974; 25():39-51. PubMed ID: 4596234
    [No Abstract]   [Full Text] [Related]  

  • 18. High remission-induction rate in acute myeloid leukaemia.
    Gale RP; Cline MJ
    Lancet; 1977 Mar; 1(8010):497-9. PubMed ID: 65605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful re-induction therapy for acute myelogenous leukemia with cytosine arabinoside and daunorubicin.
    Stein RS; Flexner JM
    Cancer Treat Rep; 1979; 63(11-12):2123-4. PubMed ID: 294309
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of adult acute non-lymphoblastic leukemia using intermittent combination chemotherapy with daunomycin, cytosine arabinoside, 6-mercaptopurine and prednisolone-DCMP two step therapy.
    Uzuka Y; Liong SK; Yamagata S
    Tohoku J Exp Med; 1976; 118 Suppl():217-25. PubMed ID: 1067159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.